DK0766682T3 - Proteinkinase-C-inhibitorer - Google Patents

Proteinkinase-C-inhibitorer

Info

Publication number
DK0766682T3
DK0766682T3 DK95923985T DK95923985T DK0766682T3 DK 0766682 T3 DK0766682 T3 DK 0766682T3 DK 95923985 T DK95923985 T DK 95923985T DK 95923985 T DK95923985 T DK 95923985T DK 0766682 T3 DK0766682 T3 DK 0766682T3
Authority
DK
Denmark
Prior art keywords
beta
protein kinase
inhibitors
isozyme
present
Prior art date
Application number
DK95923985T
Other languages
Danish (da)
English (en)
Inventor
James Ronald Gillig
Michael Robert Jirousek
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/263,912 external-priority patent/US5481003A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0766682T3 publication Critical patent/DK0766682T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95923985T 1994-06-22 1995-06-19 Proteinkinase-C-inhibitorer DK0766682T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/263,912 US5481003A (en) 1994-06-22 1994-06-22 Protein kinase C inhibitors
US08/404,218 US5491242A (en) 1994-06-22 1995-03-15 Protein kinase C inhibitors
PCT/US1995/007791 WO1995035294A1 (en) 1994-06-22 1995-06-19 Protein kinase c inhibitors

Publications (1)

Publication Number Publication Date
DK0766682T3 true DK0766682T3 (da) 2001-10-08

Family

ID=26950130

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95923985T DK0766682T3 (da) 1994-06-22 1995-06-19 Proteinkinase-C-inhibitorer

Country Status (11)

Country Link
US (1) US5491242A (el)
EP (1) EP0766682B1 (el)
JP (1) JPH10502910A (el)
AT (1) ATE203991T1 (el)
AU (1) AU2866995A (el)
DE (1) DE69522109T2 (el)
DK (1) DK0766682T3 (el)
ES (1) ES2159318T3 (el)
GR (1) GR3037074T3 (el)
PT (1) PT766682E (el)
WO (1) WO1995035294A1 (el)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL126272A0 (en) * 1996-03-20 1999-05-09 Lilly Co Eli Synthesis of indolylmaleimides
AU736333B2 (en) 1996-05-01 2001-07-26 Eli Lilly And Company Therapeutic treatment for VEGF related diseases
UA54427C2 (uk) * 1996-05-01 2003-03-17 Елі Ліллі Енд Компані Спосіб лікування очних захворювань, які пов'язані з фактором васкулярного ендотеліального росту
US6232299B1 (en) 1996-05-01 2001-05-15 Eli Lilly And Company Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
US6093709A (en) * 1996-08-22 2000-07-25 Eli Lilly And Company Therapeutic treatment for sexual dysfunctions
US5962446A (en) * 1996-08-30 1999-10-05 Eli Lilly And Company Therapetutic treatment for human T cell lymphotrophic virus type 1 infection
US6107327A (en) * 1996-08-30 2000-08-22 Eli Lilly And Company Therapeutic treatment for HIV infection
US6093740A (en) * 1997-04-30 2000-07-25 Eli Lilly And Company Therapeutic treatment for skin disorders
CA2227688C (en) 1998-01-16 2007-07-31 James W. Critchfield Methods and compositions for inhibition of viral replication
US6103713A (en) * 1998-03-05 2000-08-15 Eli Lilly And Company Therapeutic treatment for autoimmune diseases
US6225301B1 (en) 1998-03-05 2001-05-01 Eli Lilly And Company Therapeutic treatment for renal dysfunction
US6103712A (en) * 1998-03-05 2000-08-15 Eli Lilly And Company Therapeutic treatment for asthma
US6291446B1 (en) 1998-03-05 2001-09-18 Eli Lilly And Company Therapeutic treatment for cytomegalovirus infection
US6013646A (en) 1998-07-02 2000-01-11 Bayer Corporation Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer
US6492406B1 (en) * 1999-05-21 2002-12-10 Astrazeneca Ab Pharmaceutically active compounds
US6284783B1 (en) 1999-06-09 2001-09-04 The Uab Research Foundation Use of bisindolylmaleimide compounds to induce Fas-mediated apoptosis
DE10244453A1 (de) 2002-09-24 2004-04-01 Phenomiques Gmbh Hemmung der Proteinkinase C-alpha zur Behandlung von Krankheiten
US20040175384A1 (en) * 2003-12-12 2004-09-09 Mohapatra Shyam S. Protein kinase C as a target for the treatment of respiratory syncytial virus
US8592368B2 (en) 2003-12-19 2013-11-26 University Of South Florida JAK/STAT inhibitors and MAPK/ERK inhibitors for RSV infection
US20080182801A1 (en) 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
GB0329667D0 (en) 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
GB0513881D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
US8158586B2 (en) * 2005-04-11 2012-04-17 Pharmagap Inc. Inhibitors of protein kinases and uses thereof
GB0513888D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
EP1940395A2 (en) 2005-09-16 2008-07-09 Schering Corporation Pharmaceutical compositions and methods using temozolomide and a protein kinase inhibitor
GB0605691D0 (en) * 2006-03-21 2006-05-03 Novartis Ag Organic Compounds
US8193236B2 (en) 2006-12-19 2012-06-05 Novartis Ag Indolylmaleimide derivatives processes for their production and pharmaceutical compositions
CN104398508B (zh) * 2014-11-28 2017-06-13 上海交通大学 双吲哚马来酰亚胺衍生物在制备治疗慢性粒细胞白血病药物中的应用
CN104693198B (zh) * 2014-12-13 2017-03-08 浙江工业大学 3‑(1,2,4‑三氮唑并[4,3‑a]吡啶‑3‑基)‑4‑(1H‑吲哚‑3‑基)马来酰亚胺类衍生物及其制备方法和应用
CN106146475B (zh) * 2016-06-01 2019-05-17 中国海洋大学 双吲哚马来酰亚胺衍生物及其制备方法和用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
US4923986A (en) * 1987-03-09 1990-05-08 Kyowa Hakko Kogyo Co., Ltd. Derivatives of physiologically active substance K-252
DE3803620A1 (de) * 1988-02-06 1989-08-17 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
NZ227850A (en) * 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
MC2096A1 (fr) * 1989-02-23 1991-02-15 Hoffmann La Roche Pyrroles substitues
DE3914764A1 (de) * 1989-05-05 1990-11-08 Goedecke Ag Maleinimid-derivate und deren verwendung als arzneimittel
PT93947B (pt) * 1989-05-05 1996-11-29 Goedecke Ag Processo para a preparacao de novos derivados de maleinimidas e de composicoes farmaceuticas que os contem
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
DE3942296A1 (de) * 1989-12-21 1991-06-27 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung
DE4005970A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte maleinimide, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
DE4005969A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
CA2046801C (en) * 1990-08-07 2002-02-26 Peter D. Davis Substituted pyrroles
GB9123396D0 (en) * 1991-11-04 1991-12-18 Hoffmann La Roche A process for the manufacture of substituted maleimides
AU3761393A (en) * 1992-03-20 1993-10-21 Wellcome Foundation Limited, The Indole derivatives with antiviral activity
DE4217964A1 (de) * 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung
AU5100393A (en) * 1992-09-25 1994-04-26 Schering Corporation Diindolo compounds and pharmaceutical compositions containing them
DE4243321A1 (de) * 1992-12-21 1994-06-23 Goedecke Ag Aminosäurederivate von Heterocyclen als PKC-Inhibitoren

Also Published As

Publication number Publication date
DE69522109T2 (de) 2002-04-18
EP0766682A1 (en) 1997-04-09
US5491242A (en) 1996-02-13
AU2866995A (en) 1996-01-15
DE69522109D1 (de) 2001-09-13
ATE203991T1 (de) 2001-08-15
EP0766682A4 (en) 1997-09-10
PT766682E (pt) 2001-11-30
ES2159318T3 (es) 2001-10-01
JPH10502910A (ja) 1998-03-17
GR3037074T3 (en) 2002-01-31
WO1995035294A1 (en) 1995-12-28
EP0766682B1 (en) 2001-08-08

Similar Documents

Publication Publication Date Title
DK0766682T3 (da) Proteinkinase-C-inhibitorer
ATE456367T1 (de) Proteinkinase c inhibitoren
ATE234092T1 (de) 2-alkylpyrrolidine
CA2376596A1 (en) Humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodies
TR199501643A2 (tr) Yünün enzimlerle tedavisi icin yöntem.
NZ324921A (en) Cathepsin K crystal structure and methods of identifying inhibitors of this protease
WO2001079460A3 (en) Polypeptides having haloperoxidase activity
AU2002366641A1 (en) Methods for inhibiting ocular processes
AU7585598A (en) Raf kinase inhibitors
AU9536898A (en) 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the holesterin-ester transfer protein
LV12125A (lv) Ciklofilina rotamazes aktivitates inhibitori
WO2005044093A3 (en) Delta-9- the treatment of multiple sclerosis
ES2088771A1 (es) Metodo para mejorar la acividad reproductora en verracos utilizando alimento para los verracos reproductores.
DE3861462D1 (de) Gasfeuerzeugstruktur, geeignet zur andrueckmontage seiner hauptteile.
IL142220A0 (en) Method of treating viral hemorrhagic fever
WO2001087239A3 (en) Methods of affecting laminin 5 processing
IL139303A0 (en) Treatment of arthritis and other similar conditions
BR9915572A (pt) Processo de tratamento de doença de célula falciforme e talassemia
BR9915317A (pt) Método de tratar trombocitopenia induzida por heparina
WO2000058506A3 (en) Susceptibility to psoriasis
WO2004017909A3 (en) Methods of reducing ischemic injury
WO2001029071A3 (en) Genes associated with obesity and methods for using the same
ES2122912A1 (es) Inhibidores de metalocarboxipeptidasas y moleculas derivadas como agentes antitumorales.
FI982630A (fi) Menetelmä 2,6-dimetyylinaftaleenin valmistamiseksi
CA2193703A1 (en) Protein kinase c inhibitors